Terpene Research

Clinical Outlook: The Future of Inhalable Terpene Therapy

Reviewing active clinical trials and EEG studies exploring the immediate calming effects of beta-caryophyllene.

var(--variable-loc4ByaKL)

Written by

Eybna

R&D Team

var(--variable-loc4ByaKL)

Written by

Eybna

R&D Team

Inhalation remains one of the most efficient pathways for botanical therapeutics, allowing active ingredients to interact immediately with olfactory receptors and enter the bloodstream. Our research team is currently conducting clinical trials validating these benefits.

The Olfactory-Limbic Highway

When inhaled, volatile terpene compounds bind to olfactory receptors, sending immediate electrical signals to the limbic system—the brain's emotional control center. This pathway bypasses the digestive tract and liver metabolism entirely, allowing for near-instantaneous physiological effects within seconds of inhalation.

EEG Mapping & High-Density Leads

Our ongoing clinical trials use 64-channel high-density EEG mapping to track brain state changes. By measuring the electrical potential of the cerebral cortex before, during, and after terpene inhalation, we have documented immediate increases in alpha wave power, indicating a state of relaxed alertness without drowsiness.

Verifiable Stress Mitigation

Recent double-blind trials showed that inhalation of our targeted terpene blends produced a significant, rapid decrease in heart rate variability and cortisol levels, backed by real-time EEG brainwave calming. This clinical verification is paving the way for next-generation wellness devices and standardized therapeutic inhalers.